Dr. Anand Jeyasekharan is a principal investigator at the Cancer Science Institute (CSI) of Singapore, a consultant medical oncologist at the Department of Haematology-Oncology at the National University Hospital (NUH), Singapore, and a platform lead for the Singapore Translational Cancer Consortium (STCC). He obtained his undergraduate medical degree at Christian Medical College, Vellore, India, followed by a PhD in Oncology at the University of Cambridge, UK on a Gates Cambridge Scholarship, and completed specialist training in Internal Medicine and Medical Oncology at NUH Singapore. Dr. Jeyasekharan's clinical and research pursuits are closely aligned, with a focus on the treatment of lymphomas/sarcomas and personalized therapies for these complex cancers. His research incorporates advanced spatial and imaging assays to understand the interplay between tumour cells and the immune microenvironment in the context of chemotherapy sensitivity and resistance.